INTERNATIONAL TREATIES AND CHINESE IMPACT IN GENERICS PRODUCTION
Keywords:
Abstract
Production, distribution, and consumption of generic pharmaceuticalshas had an increasing effect on the pharma industry worldwide. In recent years, the market for the production of generics has developed various adaptations to suit different structures of demand, legislation, and distribution. Increased level of expenditure on medicines worldwide due to spiking demand has sparked a sea change in related government policies and statutes. A broadoutline of the international framework of generics markets and their development helps inform a focused case study on an emerging player in the field, China, and their predicted effect on the pharmaceutical industry.Detailed analysis of the international recognition of intellectual property, the impact of the Trade Related Aspects of Intellectual Property Rights agreement (TRIPS) on the pharmaceutical industry, and different perspectives about the development of generics production in China – employing qualitative methodology and several quantitative data – reveals the broad influence of Chinese generics.
References
Christopher May and Susan K. Sell. Intellectual Property Rights: A Critical History (2006).
Debora J. Halbert, Resisting Intellectual Property 96 (2005).
Donald G. Richards, Intellectual Property Rights and Global Capitalism: The Political Economy of the TRIPS Agreement 112 (2004)
Duncan Matthews, Globalizing Intellectual Property Rights: The TRIPs Agreement 22 (2002)
Johanna Gibson, Intellectual Property, Medicine, and Health: Current Debates 45 (2009).
World Trade Organization. Agreement on Trade Related Aspects of Intellectual Property Rights. 1994.
World Trade Organization, “Compulsory licensing of pharmaceuticals and TRIPS.”
Ling Wang, China targets patented drugs with law change, available at http://www.rsc.org/chemistryworld/2012/07/china-targets-patented-drugs-law-change (2012)
WHO Technical Report Series, no 961, page 289, available at
http://apps.who.int/prequal/info_general/documents/TRS961/TRS961_Annex7.pdf, (2011)
API Manufacturing, George Karris, August 2005, available at http://www.contractpharma.com/issues/2002-09/view_features/api-manufacturing/, accessed in December 2015
Law Against Unfair Competition of the People’s Republic of China (1993) available at http://www.ccpit-patent.com.cn/node/1245/1247
Patent Law of The People`s Republic of China (2008), available at http://www.ccpit-patent.com.cn/node/1068/1128
Will China Take Over Generics Production?, November 2015, available at
http://languageconnections.com/blog/will-china-take-over-generics-manufacturing/, accessed in December 2015.
China Food and Drug Administration, Provisions for drug registration available at http://eng.sfda.gov.cn/WS03/CL0768/61645.html, accessed in November 2015.
China targets more efficient generics drugs production, Xinhua, December 2015,
http://china.org.cn/china/2015-12/04/content_37231580.htm
Eric Langer, Biogenerics in China: An evolving industry, published on Biopharm International, www.biopharminternational.com 2007.
Eric Mu, Low-cost drug list to transform pharmaceutical industry in China, http://www.danwei.com/low-cost-drug-list-to-change-pharma-in-china/, 2013
Cindy Wu. Competition in China’s generic drug market intensifies. Asia Manufacturing Pharma. 2009 Sep 9, available on http://www.gabionline.net/Generics/General/Competition-in-China-s-generic-drug-market-intensifies
Generics in China, available at http://www.marketresearch.com/MarketLine-v3883/Generics-China-8747597/
Downloads
Published
Issue
Section
License
Copyright Notice
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication.
Copyrights for articles published in World Scholars journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.
